These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 29958127)
1. Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial. Moore DJ; Pasipanodya EC; Umlauf A; Rooney AS; Gouaux B; Depp CA; Atkinson JH; Montoya JL Drug Alcohol Depend; 2018 Aug; 189():154-160. PubMed ID: 29958127 [TBL] [Abstract][Full Text] [Related]
2. Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder. Moore DJ; Poquette A; Casaletto KB; Gouaux B; Montoya JL; Posada C; Rooney AS; Badiee J; Deutsch R; Letendre SL; Depp CA; Grant I; Atkinson JH; AIDS Behav; 2015 Mar; 19(3):459-71. PubMed ID: 25504449 [TBL] [Abstract][Full Text] [Related]
3. A Culturally Adapted SMS Text Messaging Intervention to Promote Antiretroviral Therapy Adherence Among African Americans: Protocol for a Single-Arm Trial. Kohli M; Pasipanodya EC; Montoya JL; Marquine M; Hoenigl M; Serrano V; Cushman C; Garcia R; Kua J; Gant V; Rojas S; Moore DJ JMIR Res Protoc; 2020 Dec; 9(12):e21592. PubMed ID: 33300885 [TBL] [Abstract][Full Text] [Related]
4. Preliminary Evidence for Feasibility, Use, and Acceptability of Individualized Texting for Adherence Building for Antiretroviral Adherence and Substance Use Assessment among HIV-Infected Methamphetamine Users. Moore DJ; Montoya JL; Blackstone K; Rooney A; Gouaux B; Georges S; Depp CA; Atkinson JH; Tmarc Group T AIDS Res Treat; 2013; 2013():585143. PubMed ID: 24078868 [TBL] [Abstract][Full Text] [Related]
5. Pilot RCT of bidirectional text messaging for ART adherence among nonurban substance users with HIV. Ingersoll KS; Dillingham RA; Hettema JE; Conaway M; Freeman J; Reynolds G; Hosseinbor S Health Psychol; 2015 Dec; 34S(0):1305-15. PubMed ID: 26651472 [TBL] [Abstract][Full Text] [Related]
6. Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. Dowshen N; Kuhns LM; Johnson A; Holoyda BJ; Garofalo R J Med Internet Res; 2012 Apr; 14(2):e51. PubMed ID: 22481246 [TBL] [Abstract][Full Text] [Related]
7. Feasibility of interactive text message response (ITR) as a novel, real-time measure of adherence to antiretroviral therapy for HIV+ youth. Dowshen N; Kuhns LM; Gray C; Lee S; Garofalo R AIDS Behav; 2013 Jul; 17(6):2237-43. PubMed ID: 23546844 [TBL] [Abstract][Full Text] [Related]
8. Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study. Morris SR; Jain S; Blumenthal J; Bolan R; Dubé MP; Henderson P; Corado K; Sun S; He F; Chow K; Burke L; Anderson PL; Moore DJ J Acquir Immune Defic Syndr; 2022 Dec; 91(5):453-459. PubMed ID: 36084200 [TBL] [Abstract][Full Text] [Related]
9. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. Moore DJ; Blackstone K; Woods SP; Ellis RJ; Atkinson JH; Heaton RK; Grant I; AIDS Care; 2012; 24(12):1504-13. PubMed ID: 22530794 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of Psychoeducation and a Text Messaging Adherence Intervention Among Individuals With Hypertension and Bipolar Disorder. Levin JB; Sajatovic M; Rahman M; Aebi ME; Tatsuoka C; Depp C; Cushman C; Johnston E; Cassidy KA; Blixen C; Eskew L; Klein PJ; Fuentes-Casiano E; Moore DJ Psychiatr Serv; 2019 Jul; 70(7):608-612. PubMed ID: 30991908 [TBL] [Abstract][Full Text] [Related]
11. Using mHealth to improve adherence and reduce blood pressure in individuals with hypertension and bipolar disorder (iTAB-CV): study protocol for a 2-stage randomized clinical trial. Levin JB; Moore DJ; Depp C; Montoya JL; Briggs F; Rahman M; Stange KC; Einstadter D; Weise C; Conroy C; Yala J; Radatz E; Sajatovic M Trials; 2022 Jun; 23(1):539. PubMed ID: 35768875 [TBL] [Abstract][Full Text] [Related]
12. Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study. Moore DJ; Jain S; Dubé MP; Daar ES; Sun X; Young J; Corado K; Ellorin E; Milam J; Collins D; Blumenthal J; Best BM; Anderson P; Haubrich R; Morris SR Clin Infect Dis; 2018 May; 66(10):1566-1572. PubMed ID: 29228144 [TBL] [Abstract][Full Text] [Related]
13. Positive STEPS - a randomized controlled efficacy trial of an adaptive intervention for strengthening adherence to antiretroviral HIV treatment among youth: study protocol. Mimiaga MJ; Kuhns LM; Biello KB; Olson J; Hoehnle S; Santostefano CM; Hughto JMW; Safi H; Salhaney P; Chen D; Garofalo R BMC Public Health; 2018 Jul; 18(1):867. PubMed ID: 30001703 [TBL] [Abstract][Full Text] [Related]
14. Development of a personalized bidirectional text messaging tool for HIV adherence assessment and intervention among substance abusers. Ingersoll K; Dillingham R; Reynolds G; Hettema J; Freeman J; Hosseinbor S; Winstead-Derlega C J Subst Abuse Treat; 2014 Jan; 46(1):66-73. PubMed ID: 24029625 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of Daily Text Messaging to Support Adherence to HIV Pre-Exposure Prophylaxis (PrEP) among Stimulant-Using Men Who Have Sex with Men. Serrano VB; Moore DJ; Morris S; Tang B; Liao A; Hoenigl M; Montoya JL Subst Use Misuse; 2023; 58(3):465-469. PubMed ID: 36659873 [No Abstract] [Full Text] [Related]
16. Positive Strategies to Enhance Problem-Solving Skills (STEPS): A Pilot Randomized, Controlled Trial of a Multicomponent, Technology-Enhanced, Customizable Antiretroviral Adherence Intervention for HIV-Infected Adolescents and Young Adults. Mimiaga MJ; Bogart LM; Thurston IB; Santostefano CM; Closson EF; Skeer MR; Biello KB; Safren SA AIDS Patient Care STDS; 2019 Jan; 33(1):21-24. PubMed ID: 30601059 [TBL] [Abstract][Full Text] [Related]
17. Attitudes, Beliefs, and Willingness Toward the Use of mHealth Tools for Medication Adherence in the Florida mHealth Adherence Project for People Living With HIV (FL-mAPP): Pilot Questionnaire Study. Morano JP; Clauson K; Zhou Z; Escobar-Viera CG; Lieb S; Chen IK; Kirk D; Carter WM; Ruppal M; Cook RL JMIR Mhealth Uhealth; 2019 Jul; 7(7):e12900. PubMed ID: 31271150 [TBL] [Abstract][Full Text] [Related]
18. Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV. Pasipanodya EC; Kohli M; Fisher CB; Moore DJ; Curtis B Harm Reduct J; 2020 Jun; 17(1):41. PubMed ID: 32527276 [TBL] [Abstract][Full Text] [Related]
19. Text Messaging Adherence Intervention for Adolescents and Young Adults with Chronic Kidney Disease: Pilot Randomized Controlled Trial and Stakeholder Interviews. Eaton C; Comer M; Pruette C; Psoter K; Riekert K J Med Internet Res; 2020 Aug; 22(8):e19861. PubMed ID: 32795983 [TBL] [Abstract][Full Text] [Related]
20. Preintervention Profiles of Information, Motivational, and Behavioral Self-Efficacy for Methamphetamine Use and HIV Medication Adherence Among Gay and Bisexual Men. Starks TJ; Millar BM; Lassiter JM; Parsons JT AIDS Patient Care STDS; 2017 Feb; 31(2):78-86. PubMed ID: 28092450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]